1Taras Shevchenko Kyiv National University, Ukraine.
2Interregional Academy of Personnel Management, Ukraine.
Georgian Med News. 2024 Jan(346):113-118.
The purpose of the article is to find out the scope of the criminal law protection of the circulation of medicinal products according to the legislation of the Federal Republic of Germany, the Republic of Austria, and the Swiss Confederation. The materials of the research were the legislation of the Federal Republic of Germany, the Republic of Austria, and the Swiss Confederation. Dialectical, axiological, comparative, and legal methods were applied during the research. Having studied the experience of the scope of criminal law protection of the circulation of medicinal products made it possible to conclude about the importance of having a certain legislative reference point that can help improve the criminal legislation of these and other countries and build a new model of the system of norms that ensure the criminal law protection of circulation of medicinal products. It has been concluded that in the criminal legislation of the Federal Republic of Germany, the Republic of Austria, and the Swiss Confederation there is an "aspiration" of the legislator to ensure the most complete scope of criminal law protection of circulation of medicinal products by creating their own specific systems. It has been proposed to single out separate groups of signs of criminal protection of pharmaceutical activity, since the scope of such protection is not the same in such countries (but has a lot in common). This may be a certain legislative guideline of the systematization of norms that ensure the circulation of medicinal products from the point of view of their criminal law protection.
本文旨在根据德国联邦共和国、奥地利共和国和瑞士联邦的立法,找出药品流通刑法保护的范围。研究的材料是德国联邦共和国、奥地利共和国和瑞士联邦的立法。在研究过程中应用了辩证的、价值论的、比较的和法律的方法。研究药品流通刑法保护范围的经验表明,拥有一定的立法参考点非常重要,这有助于改进这些国家和其他国家的刑法立法,并建立一个确保药品流通刑法保护的规范体系新模式。研究结果表明,在德国联邦共和国、奥地利共和国和瑞士联邦的刑法立法中,立法者有一种“愿望”,即通过创建自己的特定制度,确保药品流通刑法保护的范围尽可能完整。有人建议,应单独列出刑事保护制药活动的标志,因为这些国家的这种保护范围不同(但有很多共同之处)。这可能是从刑法保护的角度确保药品流通的规范系统化的某种立法指导方针。